Substrate reduction therapy in patients with mild-to-moderate type i gaucher disease

被引：0
|
作者：
Vicente, Cristina [1 ]
Jose Agustin, M. [1 ]
Navarro, Herminia [1 ]
Picaza, Estibaliz [1 ]
Arenere, Mercedes [1 ]
Idoipe, Angela [1 ]
机构：
[1] Univ Hosp Miguel Servet, Serv Pharm, Zaragoza, Spain
来源：
PHARMACY WORLD & SCIENCE | 2009年 / 31卷 / 01期
关键词：
Gaucher disease; Miglustat; Drug's use;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [1] BALANCED ORAL SUBSTRATE REDUCTION THERAPY FOR PATIENTS WITH MILD TO MODERATE GAUCHER DISEASE: ONE YEAR IN CLINICAL PRACTICE
    Hughes, D.
    Baker, R.
    Richfield, L.
    Milligan, A.
    Goodwin, S.
    Blincoe, M.
    Bruce, R.
    Mehta, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 172 - 172
  • [2] Balanced oral substrate reduction therapy for patients with mild to moderate Gaucher's disease: Initial results in clinical practice.
    Hughes, DA
    Baker, RJ
    Richfield, L
    Milligan, A
    Bruce, R
    Mehta, AB
    BLOOD, 2004, 104 (11) : 41B - 42B
  • [3] Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1
    Pastores, GM
    Barnett, NL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 273 - 281
  • [4] Eliglustat substrate reduction therapy in pediatric patients with Gaucher disease
    Saith, Armaan
    Basiri, Mohsen
    Yang, Ruhua
    Mistry, Pramod K.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [5] Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease
    Moyses, C
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2003, 358 (1433) : 955 - 960
  • [6] Eliglustat substrate reduction therapy in children with Gaucher disease type 1
    Ul Ain, Noor
    Saith, Armaan
    Ruan, Audrey
    Yang, Ruhua
    Burton, Aaron
    Mistry, Pramod K.
    FRONTIERS IN PEDIATRICS, 2025, 13
  • [7] Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy
    Hansson, L
    Smith, DHG
    Reeves, R
    Lapuerta, P
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (11) : 1654 - 1658
  • [8] Eliglustat substrate reduction therapy in Gaucher disease patients with cardiac comorbidities
    Saith, Armaan
    Basiri, Mohsen
    Yang, Ruhua
    Mistry, Pramod K.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [9] Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
    Bouwien E. Smid
    Maria J. Ferraz
    Marri Verhoek
    Mina Mirzaian
    Patrick Wisse
    Herman S. Overkleeft
    Carla E. Hollak
    Johannes M. Aerts
    Orphanet Journal of Rare Diseases, 11
  • [10] Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
    Smid, Bouwien E.
    Ferraz, Maria J.
    Verhoek, Marri
    Mirzaian, Mina
    Wisse, Patrick
    Overkleeft, Herman S.
    Hollak, Carla E.
    Aerts, Johannes M.
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
12345